Patrocinado
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Postado
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia mais
'It's okay': Yuvraj takes a cheeky dig at Australia as SA win WTC title
Yuvraj Singh celebrated South Africa's historic World Test Championship victory over Australia at...
Drama! Johnson slams Hazlewood for playing in IPL over national duty: 'We've ...'
Mitchell Johnson has criticised Josh Hazlewood's choice to play in the IPL instead of preparing...
IND vs ENG | Like England have Bashir, India should back Kuldeep: Ex-India cricketer
With Ashwin's retirement, Kuldeep Yadav is expected to lead India's spin attack in the upcoming...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese (Brazil)
